ReviewFrontiers in oncology2022

Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies.

Kamila Polgárová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.